Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in SIADH
NCT00264914Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, open-label, single-arm trial of satavaptan in syndrome of inappropriate antidiuretic hormone secretion (SIADH), sponsored by Sanofi. Primary endpoint: Safety. Started Jul 2005; status: completed.
02
Drugs
satavaptan
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Beyond the preview
Go deeper on NCT00264914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264914.